Telling.ai was founded with the core mission of leveraging artificial intelligence to analyze voice and breath sounds for the early detection of respiratory diseases. The company envisions a world where advanced AI technology assists in managing the care of over 1 billion people suffering from acute or chronic respiratory disorders. Telling.ai offers telehealth respiratory monitoring services that utilize voice and breath biometrics to identify signatures indicative of various medical conditions, including respiratory diseases and infections.
Notable affiliated individuals and investors include experts in medical technology and AI, although specific names are not provided. Key achievements of Telling.ai include the development of a sophisticated AI system capable of detecting respiratory issues through non-invasive methods. The overall impact of Telling.ai lies in its potential to revolutionize respiratory healthcare by providing early detection and continuous monitoring, thereby improving patient outcomes and reducing healthcare costs.
